Fermer le menu


Member of Lyonbiopole


Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions.


Strategic application domain: Medical Technologies

Application market: Metabolic Disorders - Endocrinology, Ophthalmology, Pneumology - Respiratory Diseases

Type of activity: CRO - Tools - R&D platform, E-Health, Medical device

Technologies: Drug delivery device & Technologies

Created on jan. 1st, 2004 - 83 employees



PT Lavaur La Béchade 63500 ISSOIRE



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.